The ITPA gene helps cells clear away unusual RNA and DNA building blocks, which supports normal cell growth and repair. If it does not work well, these substances can build up and interfere with how cells function; rare severe variants are linked to early developmental and neurologic problems, sometimes with heart involvement. More common variants in the ITPA gene often do not cause a condition on their own, but they can change how some people respond to medicines such as thiopurines.
What is a gene?
Genes are stretches of DNA that give cells instructions to make molecules or guide processes throughout the body. Some carry the code for proteins, which are the parts of cells that do the work. Others mainly regulate when a process happens, where it happens, and how active it is. Taken together, genes affect how the body grows and works, and they can also influence how you respond to food, stress, and medicines. You can find a deeper explanation of this topic in the LearnHub.
Overview
ITPAGene function
What if the gene works
The ITPA gene helps clear uncommon building blocks from cells so they do not get used in DNA and RNA. This supports steady cell function and helps protect cells from avoidable stress.
Risk
What if the gene does not work
More severe variants in the ITPA gene can cause ITPA deficiency, which may lead to developmental delay, seizures, and in some infants heart weakness. Milder variants often lower enzyme activity and may have little or no noticeable effect.
Treatment
What does that mean for your treatment
People with loss-of-function variants in the ITPA gene do not currently have a treatment plan that is specific to ITPA itself. The ITPA gene is better established as a drug-response biomarker, especially for thiopurines and ribavirin.
Conditions associated with ITPA
Gene function
What if the gene works
Your cells constantly sort and recycle the small molecules used to make DNA and RNA. The ITPA gene supports this quality control job by clearing away unusual versions before they are used. That steady cleanup helps everyday cell activity stay accurate.
The ITPA gene breaks down unusual versions of DNA and RNA building blocks, including ITP and dITP, that arise during normal cell activity. This keeps the cell’s supply of genetic ingredients cleaner and more orderly.
By clearing away the wrong building blocks before DNA is copied, the ITPA gene helps cells use the usual ingredients for new DNA strands. This supports stable genetic material during normal cell division.
The same cleanup step helps cells make RNA, the working copy of genetic instructions, from the usual building blocks. In simple terms, this is how the ITPA gene works in your cells as part of everyday genetic quality control.
What is a variant?
A genetic variant is a minor change in a gene’s DNA sequence. These changes are common and help shape normal human variation, including differences in appearance, metabolism, and the way the body responds to environmental influences. Many variants do not have any noticeable effect and are simply part of natural genetic diversity. Sometimes, though, a variant changes how a gene works more substantially and can contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the ITPA gene can make the protein unstable, misshapen, or less active, so unusual purine building blocks are not cleared well inside cells. Milder variants may leave some activity, while severe variants can leave little or none and cause more inosine containing molecules to build up in RNA and DNA. In practice, how variants influence the ITPA gene's function depends on residual activity, with lower activity linked to stronger cellular effects and, in severe inherited deficiency, earlier symptoms.
How variants are linked to conditions
Rare severe variants in both copies of the ITPA gene can cause a rare brain condition that begins in infancy and often includes seizures and major delays in development (developmental and epileptic encephalopathy). In discussions of how variants in the ITPA gene are linked to conditions, this rare childhood diagnosis is the clearest established association. More common variants in the ITPA gene are not known to cause this condition on their own.
A variant is not necessarily a diagnosis
Gene variants are a routine part of human biology and are common throughout the general population. Most do not have a direct effect on health and simply reflect natural human diversity. For many genes, carrying a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when more than one gene and environmental factors are involved. In some cases, though, a single well-characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not broadly confirmed evidence that lifestyle or everyday exposures clearly increase or reduce health risk from ITPA itself. Changes in the ITPA gene are mainly known for affecting how some medicines are tolerated, so any change in risk depends most on the exact gene change and whether those medicines are used.
Inheritance of ITPA variants
For ITPA-related disease, variants in the ITPA gene are inherited in an autosomal recessive pattern. This means a child usually needs to inherit two changed copies of the ITPA gene, one from each parent, to be affected. Parents who each carry one variant are often unaffected themselves. With each pregnancy, two carrier parents have a 25% chance of having an affected child, a 50% chance of having a child who is also a carrier, and a 25% chance of having a child with no familial variant. This is the usual answer to how ITPA gene variants are inherited in families.
What does my ITPA result mean for my family?
For the rare condition linked to the ITPA gene, the pattern is usually recessive. This means close relatives may also be carriers, and brothers or sisters could be affected if they inherited the same changed copy from both parents. Family planning questions often come up because parents of an affected child are usually carriers, and other relatives may want to learn whether the change runs in the family.
Genetic information
Genetic testing
How you find out about variants
To find out whether you carry a variant in the ITPA gene, clinicians use genetic testing for ITPA gene variants on a blood or saliva sample. A lab reads the DNA code in the ITPA gene and compares it with the usual sequence to identify variants, then reports whether a relevant change was found.
When should I consider getting a genetic test?
An ITPA genetic test may be worth discussing before starting certain medicines, especially thiopurine drugs such as azathioprine or mercaptopurine, or after unusual side effects on them. Results can help explain a higher chance of some drug-related side effects and may guide treatment planning.
A genetic result is only one part of your health story
Genetic test results can provide useful insight, but how much they reveal depends on the condition and on the type of variant involved. The way the body works over time is also shaped by many factors, including lifestyle, environment, age, and medical history. For some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is best considered alongside other parts of care. In other situations, a genetic result can offer a clear answer. In areas like medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how your body responds to medicines. Some people break down or handle a drug differently, so the same treatment may work better for one person, do less for another, or cause more side effects. This kind of difference is common and is one reason medication response can vary from person to person.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences affect the way people respond to medications. It studies gene and drug patterns to help explain why the same treatment may work differently from one person to another. For many medicines, genes influence how strongly a drug works or how the body handles it. This information can support more informed and individualized treatment decisions. To explore this topic in more detail, you can learn more in the LearnHub.
Drugs influenced by the ITPA gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding routine medication choices, so general concerns about side effects, new symptoms, or how well a treatment is working are best discussed with your doctor. Some studies have looked at ITPA changes and side effects with thiopurine medicines and ribavirin, but this has not become standard prescribing guidance.
History
The ITPA gene entered medical genetics through research on why some people reacted differently to certain medicines. First described in the scientific literature as part of early genetics, it drew wider interest when studies linked inherited ITPA variants to side effects from thiopurine drugs, which are used for some blood conditions, autoimmune diseases, and transplants. From these first observations, research expanded steadily. Scientists then identified common variants, including c.94C>A, that reduce ITPA activity and helped explain differences seen in patients during treatment. This work made the ITPA gene an established part of pharmacogenetics, the field that studies how genes influence drug response. Today, its history reflects a broader shift toward more personalized prescribing.